Prostate
Prostate carcinoma is the third most common tumor in men. Smaller tumors are difficult to detect with normal palpatory examinations, which are recommended from the age of 50. Therefore, the so-called PSA value is additionally evaluated, which can also be increased in benign diseases. Random biopsies often miss small tumors.
The multiparametric prostate MRI (mpMRI) provides a valuable contribution in many cases of early detection and is able to visualize even small tumors which can be biopsied by your urologist. MRI is the imaging technique that can display your prostate with the highest resolution and soft tissue contrast. Further information can be found on the pages of our Competence Center Prostate Imaging.
